Malaria
New invasive non-Typhoidal Salmonella epidemic identified in sub-Saharan Africa
(Medical Xpress)—A new study out today reveals that the emergence and spread of a rapidly evolving invasive intestinal disease, that has a significant mortality rate (up to 45%) in infected people in sub-Saharan ...
Genetics
Sep 30, 2012 |
5 / 5 (3) |
1
|
WHO urges action as drug-resistant malaria spreads
The World Health Organization said Thursday that governments in the Mekong region must act "urgently" to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar.
Diseases, Conditions, Syndromes
Sep 27, 2012 |
not rated yet |
0
Mutant parasite could stop malaria in its tracks
(Medical Xpress)—University of Nottingham Malaria experts have found a way of disabling one of the many phosphatase proteins which breathe life into the malaria parasite. The result is a mutant which is ...
Diseases, Conditions, Syndromes
Sep 21, 2012 |
4.5 / 5 (4) |
0
|
Cambodians fight malaria with the push of a button
Cambodian villagers armed with a little medical know-how—and their mobile telephones—are the nation's new foot soldiers in the fight against drug-resistant malaria.
Diseases, Conditions, Syndromes
Sep 17, 2012 |
not rated yet |
0
Genetic make-up of children explains how they fight malaria infection
Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria ...
Genetics
Sep 12, 2012 |
not rated yet |
0
|
Diet could combat adverse side-effects of quinine
(Medical Xpress)—Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.
Diseases, Conditions, Syndromes
Sep 11, 2012 |
not rated yet |
1
|
'Humanized' mice enable malaria research breakthrough
A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will ...
Medical research
Sep 10, 2012 |
5 / 5 (1) |
0
Are restrictions to scientific research costing lives?
In 'Censors on Campus', Index on Censorship asks whether lives might be saved by making vital research freely available. As malaria expert Bart Knols argues, in some parts of Asia and Africa the fight against malaria is sev ...
Other
Sep 05, 2012 |
not rated yet |
0
Fighting malaria with the help of personal computing power
UCD researchers, Dr Anthony Chubb and PhD student Kevin O'Brien, working with Conway Fellow, Professor Denis Shields in the Complex Adaptive Systems Laboratory (CASL) are harnessing the donated computational power of personal ...
Medical research
Sep 05, 2012 |
not rated yet |
1
Southeast Asian ovalocytosis protects against P. vivax malaria
A multinational group of authors, led by Ivo Mueller from the Walter & Eliza Hall Institute, Australia and the Papua New Guinea Institute of Medical Research, have found a strong association between Southeast Asian ovalocytosis, ...
Diseases, Conditions, Syndromes
Sep 04, 2012 |
not rated yet |
0
'Benign' malaria key driver of human evolution in Asia-Pacific
The malaria species rampant in the Asia-Pacific region has been a significant driver of evolution of the human genome, a new study has shown. An international team of researchers has shown that Plasmodium vivax malaria, the mo ...
Medical research
Sep 04, 2012 |
5 / 5 (2) |
0
|
High levels of DDT in breast milk in South Africa
The highest levels ever of DDT in breast milk have been measured in mothers living in malaria-stricken villages in South Africa. The values lie well over the limits set by the World Health Organization. DDT has been used ...
Health
Sep 03, 2012 |
not rated yet |
0
Danish scientists solve old blood mystery
Scientists at the research centre MEMBRANES at Aarhus University, Denmark, have completed an old puzzle, which since the 60s from many sides has been regarded as impossible to complete. The challenge was to solve the structure ...
Medical research
Aug 31, 2012 |
5 / 5 (3) |
0
Protein impedes microcirculation of malaria-infected red blood cells
(Medical Xpress)—When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the ...
Medical research
Aug 30, 2012 |
not rated yet |
0
|
Malaria nearly eliminated in Sri Lanka despite decades of conflict
(Medical Xpress)—Despite nearly three decades of conflict, Sri Lanka has succeeded in reducing malaria cases by 99.9 percent since 1999 and is on track to eliminate the disease entirely by 2014.
Diseases, Conditions, Syndromes
Aug 30, 2012 |
not rated yet |
0
Malaria is a mosquito-borne infectious disease of humans and other animals caused by eukaryotic protists of the genus Plasmodium. The disease results from the multiplication of Plasmodium parasites within red blood cells, causing symptoms that typically include fever and headache, in severe cases progressing to coma or death. It is widespread in tropical and subtropical regions, including much of Sub-Saharan Africa, Asia, and the Americas.
Five species of Plasmodium can infect and be transmitted by humans. Severe disease is largely caused by Plasmodium falciparum while the disease caused by Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae is generally a milder disease that is rarely fatal. Plasmodium knowlesi is a zoonosis that causes malaria in macaques but can also infect humans.
Malaria transmission can be reduced by preventing mosquito bites by distribution of mosquito nets and insect repellents, or by mosquito-control measures such as spraying insecticides and draining standing water (where mosquitoes breed). Despite a clear need, no vaccine offering a high level of protection currently exists. Efforts to develop one are ongoing. A number of medications are also available to prevent malaria in travelers to malaria-endemic countries (prophylaxis).
A variety of antimalarial medications are available. Severe malaria is treated with intravenous or intramuscular quinine or, since the mid-2000s, the artemisinin derivative artesunate, which is superior to quinine in both children and adults. Resistance has developed to several antimalarial drugs, most notably chloroquine.
There were an estimated 225 million cases of malaria worldwide in 2009. An estimated 655,000 people died from malaria in 2010, a 5% decrease from the 781,000 who died in 2009 according to the World Health Organization's 2011 World Malaria Report, accounting for 2.23% of deaths worldwide. Ninety percent of malaria-related deaths occur in sub-Saharan Africa, with ~60% of deaths being young children under the age of five. Plasmodium falciparum, the most severe form of malaria, is responsible for the vast majority of deaths associated with the disease. Malaria is commonly associated with poverty, and can indeed be a cause of poverty and a major hindrance to economic development.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Vicious cycle: Obesity sustained by changes in brain biochemistry
With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...
White matter imaging provides insight into human and chimpanzee aging
(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...